The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 37,943 | 2,410,622 | SH | SOLE | 2,410,622 | 0 | 0 | ||
| ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 11,033 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 25,315 | 743,472 | SH | SOLE | 743,472 | 0 | 0 | ||
| ALLAKOS INC | COM | 01671P100 | 10,058 | 1,643,500 | SH | SOLE | 1,643,500 | 0 | 0 | ||
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 9,540 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 13,355 | 404,078 | SH | SOLE | 404,078 | 0 | 0 | ||
| BCLS ACQUISITION CORP | COM CL A | G0904B105 | 2,505 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 54,158 | 5,128,557 | SH | SOLE | 5,128,557 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 9,241 | 920,464 | SH | SOLE | 920,464 | 0 | 0 | ||
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 15,146 | 538,812 | SH | SOLE | 538,812 | 0 | 0 | ||
| COGENT BIOSCIENCES INC | COM | 19240Q201 | 64,454 | 4,319,940 | SH | SOLE | 4,319,940 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 20,085 | 5,738,500 | SH | SOLE | 5,738,500 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 43,297 | 893,646 | SH | SOLE | 893,646 | 0 | 0 | ||
| DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 14,815 | 739,661 | SH | SOLE | 739,661 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 5,368 | 103,494 | SH | SOLE | 103,494 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 3,132 | 467,468 | SH | SOLE | 467,468 | 0 | 0 | ||
| IMMUNIC INC | COM | 4525EP101 | 2,822 | 893,013 | SH | SOLE | 893,013 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 4,535 | 312,553 | SH | SOLE | 312,553 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 10,568 | 1,935,609 | SH | SOLE | 1,935,609 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 12,286 | 899,407 | SH | SOLE | 899,407 | 0 | 0 | ||
| LARIMAR THERAPEUTICS INC | COM | 517125100 | 2,400 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 52,394 | 2,615,762 | SH | SOLE | 2,615,762 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 3,315 | 1,210,000 | SH | SOLE | 1,210,000 | 0 | 0 | ||
| SATSUMA PHARMACEUTICALS INC | COM | 80405P107 | 22,268 | 3,711,286 | SH | SOLE | 3,711,286 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 17,737 | 738,110 | SH | SOLE | 738,110 | 0 | 0 | ||
| TERNS PHARMACEUTICALS INC | COM | 880881107 | 1,213 | 205,870 | SH | SOLE | 205,870 | 0 | 0 | ||
| THIRD HARMONIC BIO INC | COM | 88427A107 | 19,322 | 1,018,569 | SH | SOLE | 1,018,569 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 20,702 | 1,975,403 | SH | SOLE | 1,975,403 | 0 | 0 | ||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 55,302 | 2,696,340 | SH | SOLE | 2,696,340 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 57,577 | 1,594,932 | SH | SOLE | 1,594,932 | 0 | 0 | ||